JPH06507172A
(ja)
*
|
1991-04-19 |
1994-08-11 |
アフィニティー バイオテック,インコーポレイテッド |
転換可能なミクロエマルジョン処方剤
|
US5688761A
(en)
*
|
1991-04-19 |
1997-11-18 |
Lds Technologies, Inc. |
Convertible microemulsion formulations
|
WO1994008603A1
(en)
*
|
1992-10-16 |
1994-04-28 |
Smithkline Beecham Corporation |
Compositions
|
JPH08505367A
(ja)
*
|
1992-10-16 |
1996-06-11 |
スミスクライン・ビーチャム・コーポレイション |
医薬用エマルジョン組成物
|
AU679013B2
(en)
*
|
1992-10-16 |
1997-06-19 |
Ibah, Inc. |
Convertible microemulsion formulations
|
EP0666752A4
(de)
*
|
1992-10-16 |
1996-09-11 |
Smithkline Beecham Corp |
Therapeutische mikroemulsionen.
|
DK17093D0
(da)
*
|
1993-02-15 |
1993-02-15 |
Lyfjathroun H F |
Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
|
JPH06279228A
(ja)
*
|
1993-03-30 |
1994-10-04 |
Kao Corp |
発泡性組成物
|
US5948825A
(en)
*
|
1993-04-19 |
1999-09-07 |
Institute For Advanced Skin Research Inc. |
Microemulsion preparation containing a slightly absorbable substance
|
US6191105B1
(en)
*
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
US5514670A
(en)
*
|
1993-08-13 |
1996-05-07 |
Pharmos Corporation |
Submicron emulsions for delivery of peptides
|
US5744155A
(en)
*
|
1993-08-13 |
1998-04-28 |
Friedman; Doron |
Bioadhesive emulsion preparations for enhanced drug delivery
|
JPH09512037A
(ja)
*
|
1993-09-29 |
1997-12-02 |
コンソルツイオ・テクノバイオチツプ・ソチエタ・コンソルテイレ・エイ・アール・エル |
タンパク質薄フィルム及びその製造で用いるための組成物
|
DE4335045A1
(de)
*
|
1993-10-14 |
1995-04-20 |
Henkel Kgaa |
Fließfähiges Emulsionskonzentrat
|
DE69434626D1
(de)
*
|
1993-11-17 |
2006-04-20 |
Athena Neurosciences Inc |
Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
|
CA2185803C
(en)
*
|
1994-03-18 |
2006-07-11 |
Edward M. Rudnic |
Emulsified drug delivery systems
|
US5672358A
(en)
*
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
GB9412394D0
(en)
*
|
1994-06-21 |
1994-08-10 |
Danbiosyst Uk |
Colonic drug delivery composition
|
JPH0827018A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sanwa Kagaku Kenkyusho Co Ltd |
生理活性ペプチド又は蛋白質を含有する薬剤組成物
|
US5707641A
(en)
*
|
1994-10-13 |
1998-01-13 |
Pharmaderm Research & Development Ltd. |
Formulations comprising therapeutically-active proteins or polypeptides
|
AU698317B2
(en)
|
1995-02-25 |
1998-10-29 |
Cancer Research Technology Limited |
Transgenic animals as model of psoriasis
|
DE19509079A1
(de)
*
|
1995-03-15 |
1996-09-19 |
Beiersdorf Ag |
Kosmetische oder dermatologische Mikroemulsionen
|
US6689370B1
(en)
|
1995-04-20 |
2004-02-10 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
US6117432A
(en)
*
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
FR2733151B1
(fr)
*
|
1995-04-20 |
1997-05-23 |
Seppic Sa |
Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
|
US6008228A
(en)
*
|
1995-06-06 |
1999-12-28 |
Hoffman-La Roche Inc. |
Pharmaceutical compositions containing proteinase inhibitors
|
US5766636A
(en)
*
|
1995-09-06 |
1998-06-16 |
Natura, Inc. |
Edible, low calorie compositions of a carrier and an active ingredient and methods for preparation thereof
|
SE9503143D0
(sv)
|
1995-09-12 |
1995-09-12 |
Astra Ab |
New preparation
|
ES2277339T3
(es)
*
|
1995-11-30 |
2007-07-01 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Vacuna con adyuvante de aceite y metodo para su preparacion.
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
WO1997029773A1
(fr)
*
|
1996-02-13 |
1997-08-21 |
The Nisshin Oil Mills, Ltd. |
Emulsion et poudre renfermant un vaccin et destinees a une administration orale, et procede de production associe
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
EP0914094A4
(de)
|
1996-03-28 |
2000-03-01 |
Univ Illinois |
Materialen und verfahren zur herstellung verbesserter liposomaler mittel
|
US5726154A
(en)
*
|
1996-06-28 |
1998-03-10 |
University Of Utah Research Foundation |
Stabilization and oral delivery of calcitonin
|
DE69723375T3
(de)
*
|
1996-08-30 |
2012-12-20 |
Ajinomoto Co., Inc. |
Waschmittelzusammensetzung
|
WO1998013032A1
(en)
*
|
1996-09-27 |
1998-04-02 |
Trega Biosciences, Inc. |
Compositions of therapeutic agents suitable for oral administration
|
SE511313C2
(sv)
|
1997-01-13 |
1999-09-06 |
Gs Dev Ab |
Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US7585645B2
(en)
*
|
1997-05-27 |
2009-09-08 |
Sembiosys Genetics Inc. |
Thioredoxin and thioredoxin reductase containing oil body based products
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
FR2767064B1
(fr)
*
|
1997-08-07 |
1999-11-12 |
Centre Nat Rech Scient |
Procede de liberation d'un principe actif contenu dans une emulsion multiple
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6024786A
(en)
*
|
1997-10-30 |
2000-02-15 |
Hewlett-Packard Company |
Stable compositions of nano-particulate unmodified pigments and insoluble colorants in aqueous microemulsions, and principle of stability and methods of formation thereof
|
US20020031513A1
(en)
*
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
US6017545A
(en)
*
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
US7070799B1
(en)
*
|
1998-02-10 |
2006-07-04 |
Generex Pharmaceuticals, Inc. |
Method for administering insulin to the buccal region
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
DE19806889A1
(de)
*
|
1998-02-19 |
1999-08-26 |
Beiersdorf Ag |
Verwendung von Acyl-Carnitin
|
US20030180368A1
(en)
*
|
1998-03-14 |
2003-09-25 |
Cenes Drug Delivery Limited |
Production of microparticles
|
TWI241915B
(en)
|
1998-05-11 |
2005-10-21 |
Ciba Sc Holding Ag |
A method of preparing a pharmaceutical end formulation using a nanodispersion
|
US6241969B1
(en)
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
US8466134B1
(en)
|
1998-06-26 |
2013-06-18 |
Athena Neurosciences, Inc. |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
FR2780644B1
(fr)
*
|
1998-07-03 |
2001-07-20 |
Oreal |
Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse et d'une phase aqueuse, stabilisee a l'aide de particules de gel cubique
|
EP0976394A1
(de)
*
|
1998-07-30 |
2000-02-02 |
Biosearch Italia S.p.A. |
Neue injizierbare Formulierungen
|
EP1104290B1
(de)
|
1998-08-13 |
2010-03-31 |
Cima Labs Inc. |
Microemulsionen als feste dosisformen zur oralen verabreichung
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
DE19859427A1
(de)
*
|
1998-12-22 |
2000-06-29 |
Beiersdorf Ag |
Kosmetische oder pharmazeutische lecithinhaltige Gele oder niedrigviskose, lecithinhaltige O/W-Mikroemulsionen
|
GB9903547D0
(en)
*
|
1999-02-16 |
1999-04-07 |
Novartis Ag |
Organic compounds
|
US8119159B2
(en)
*
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
EP1064934A1
(de)
|
1999-06-30 |
2001-01-03 |
Applied Research Systems ARS Holding N.V. |
Gefriergetrocknete GRF-enthaltende Arzneimittel
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
GB0005736D0
(en)
*
|
2000-03-09 |
2000-05-03 |
G C Hahn Co Ltd |
Low fat edible emulsions
|
DE10015463B4
(de)
*
|
2000-03-29 |
2008-01-10 |
Heide, Peter Edgar, Dr. |
Creme in Form einer überwässerten Wasser-in-Öl-Emulsion
|
WO2001097837A1
(en)
*
|
2000-06-21 |
2001-12-27 |
Ferring Bv |
Solubilised protein vaccines
|
AU8436401A
(en)
|
2000-07-31 |
2002-02-13 |
Univ Bar Ilan |
Methods and pharmaceutical compositions for healing wounds
|
US20060258562A1
(en)
*
|
2000-07-31 |
2006-11-16 |
Healor Ltd. |
Methods and pharmaceutical compositions for healing wounds
|
US20100129332A1
(en)
*
|
2000-07-31 |
2010-05-27 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions for healing wounds
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030148924A1
(en)
*
|
2002-07-09 |
2003-08-07 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions of healing wounds
|
US6582682B2
(en)
*
|
2000-10-30 |
2003-06-24 |
Noville, Inc. |
Oral care compositions comprising stabilized chlorine dioxide
|
CN1406131A
(zh)
*
|
2000-12-25 |
2003-03-26 |
株式会社资生堂 |
活化交感神经的香料组合物
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6692771B2
(en)
|
2001-02-23 |
2004-02-17 |
Cima Labs Inc. |
Emulsions as solid dosage forms for oral administration
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
EP1528937B1
(de)
*
|
2001-06-05 |
2016-08-10 |
The Regents Of The University Of Michigan |
Nanoemulsionsvakzine
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
WO2003047494A2
(en)
*
|
2001-12-03 |
2003-06-12 |
Dor Biopharma Inc. |
Reverse micelle compositions and uses thereof
|
US8535650B2
(en)
*
|
2001-12-03 |
2013-09-17 |
Soligenix, Inc. |
Stabilized reverse micelle compositions and uses thereof
|
BR0307913A
(pt)
*
|
2002-02-25 |
2005-01-11 |
Lyfjathroun Hf |
Uso de uma composição, composição farmacêutica para administração nasal, e, métodos para eliciar um efeito terapêutico, profilático e/ou diagnóstico em um mamìfero, para obter um inìcio rápido de um efeito terapêutico, profilático e/ou diagnóstico de uma substância ativa em um mamìfero e para melhorar a biodisponibilidade de um efeito terapêutico, profilático e/ou diagnóstico de uma substância ativa em um mamìfero
|
US20050124705A1
(en)
*
|
2002-03-28 |
2005-06-09 |
Beiersdorf Ag |
Cosmetic or pharmaceutical, low-viscosity oil-in-water emulsions containing phospholipids
|
AU2003223005A1
(en)
*
|
2002-05-06 |
2003-11-17 |
Vectura Limited |
Application device for topical administration of pharmaceutical agents
|
AU2003236521A1
(en)
*
|
2002-06-13 |
2003-12-31 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
DE10226990A1
(de)
*
|
2002-06-18 |
2004-03-18 |
Sanguibiotech Ag |
Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff
|
CA2430889A1
(en)
*
|
2002-06-19 |
2003-12-19 |
Bayer Corporation |
Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
|
US6855332B2
(en)
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
US20040115226A1
(en)
*
|
2002-12-12 |
2004-06-17 |
Wenji Li |
Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
KR100515752B1
(ko)
*
|
2003-05-16 |
2005-09-20 |
주식회사 엘지화학 |
초임계 유체를 이용한 스티렌과 말레이미드 공중합체의제조 방법
|
US7445933B2
(en)
*
|
2003-07-16 |
2008-11-04 |
Abbott Laboratories, Inc. |
Stable calibrators or controls for measuring human natriuretic peptides
|
US7291501B2
(en)
|
2003-07-16 |
2007-11-06 |
Abbott Laboratories |
Stable compositions for measuring human natriuretic peptides
|
US7004340B2
(en)
*
|
2003-07-25 |
2006-02-28 |
Alpha Security Products, Inc. |
Bottle security device
|
AU2004263009B2
(en)
|
2003-08-07 |
2009-12-24 |
Healor Ltd. |
Pharmaceutical compositions and methods for accelerating wound healing
|
US9259390B2
(en)
*
|
2003-08-13 |
2016-02-16 |
The University Of Houston System |
Parenteral and oral formulations of benzimidazoles
|
CN1893931B
(zh)
*
|
2003-10-27 |
2011-07-20 |
陶氏康宁公司 |
局部用制剂及将活性剂传递给基底的方法
|
WO2005053612A2
(en)
*
|
2003-11-26 |
2005-06-16 |
Shire Laboratories, Inc. |
Micellar systems useful for delivery of lipophilic or hydrophobic compounds
|
PE20050596A1
(es)
*
|
2003-12-19 |
2005-10-18 |
Novartis Ag |
Microemulsion que comprende un inhibidor renina
|
US20050232974A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Gore Makarand P |
System and a method for pharmaceutical dosage preparation using jettable microemulsions
|
US20050238675A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Wenjie Li |
Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
|
US7357957B2
(en)
*
|
2004-05-07 |
2008-04-15 |
Fractec Research & Development Inc. |
Spreadable food product
|
US20070093610A1
(en)
*
|
2004-05-12 |
2007-04-26 |
Kim Dong R |
Method for preparing styrene and maleimide copolymer using super critical fluid
|
ES2618028T3
(es)
|
2004-07-19 |
2017-06-20 |
Biocon Limited |
Conjugados insulina-oligómero, formulaciones y usos de éstos.
|
US20060078623A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Emisphere Technologies, Inc. |
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
|
US20080262084A1
(en)
*
|
2004-09-13 |
2008-10-23 |
Gautam Vinod Daftary |
Stable Emulsion Compositions for Intravenous Administration Having Preservatie Efficacy
|
DE102004049574A1
(de)
|
2004-10-12 |
2006-04-20 |
Doris Dr. Barnikol-Keuten |
Arzneimittel und System zur perkutanen Arzneistoffverabreichung
|
WO2006078059A1
(ja)
*
|
2005-01-19 |
2006-07-27 |
Dainippon Sumitomo Pharma Co., Ltd. |
希釈用乳化組成物および癌ワクチン組成物
|
US20060205904A1
(en)
*
|
2005-03-11 |
2006-09-14 |
St Clair David J |
Oil gels of controlled distribution block copolymers and ester oils
|
EP2985026B1
(de)
|
2005-04-15 |
2022-08-03 |
Clarus Therapeutics, Inc. |
Systeme zur pharmazeutischen verabreichung hydrophober wirkstoffe und zusammensetzungen damit
|
US8492369B2
(en)
|
2010-04-12 |
2013-07-23 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
EP1906974A4
(de)
*
|
2005-07-22 |
2010-06-23 |
Univ California |
Heparinzusammensetzungen und selectin-hemmung
|
US20070042007A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Joseph Schwarz |
Topical composition for delivery of salicylate esters
|
EP1940440A4
(de)
*
|
2005-08-29 |
2009-11-11 |
Healor Ltd |
Verfahren und zusammensetzungen zur prävention und behandlung von diabetischer und gealterter haut
|
DOP2006000267A
(es)
*
|
2005-11-30 |
2009-06-30 |
Colgate Palmalive Company |
Composiciones y métodos de limpieza
|
US20070243132A1
(en)
*
|
2005-12-22 |
2007-10-18 |
Apollo Life Sciences Limited |
Transdermal delivery of pharmaceutical agents
|
CN101437522A
(zh)
*
|
2006-04-07 |
2009-05-20 |
默里昂研究Ⅲ有限公司 |
包含增强剂的固体口服剂型
|
GB0623838D0
(en)
*
|
2006-11-29 |
2007-01-10 |
Malvern Cosmeceutics Ltd |
Novel compositions
|
US9918934B2
(en)
*
|
2006-12-12 |
2018-03-20 |
Edgar Joel Acosta-Zara |
Linker-based lecithin microemulsion delivery vehicles
|
US7968635B2
(en)
*
|
2006-12-28 |
2011-06-28 |
Continental Ag |
Tire compositions and components containing free-flowing filler compositions
|
FR2915101B1
(fr)
*
|
2007-04-23 |
2011-07-29 |
Fabre Pierre Dermo Cosmetique |
Composition dermatologique pour la prevention et/ou le traitement de la rosacee, de la couperose ou des peaux qui presentent des rougeurs diffuses ou des petits vaisseaux dilates
|
CN101835486B
(zh)
*
|
2007-07-30 |
2012-12-12 |
希尔洛有限公司 |
用于治疗创伤的药物组合物以及相关方法
|
JP5156458B2
(ja)
*
|
2008-03-31 |
2013-03-06 |
理研ビタミン株式会社 |
ソフトカプセル充填用液状組成物
|
CN101772352B
(zh)
*
|
2007-09-27 |
2012-05-23 |
理研维他命株式会社 |
软胶囊填充用液态组合物
|
AU2008313248B2
(en)
|
2007-10-16 |
2012-04-26 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
CA2711114A1
(en)
*
|
2008-01-02 |
2009-07-16 |
Kringle Pharma Inc. |
Topical compositions for the controlled delivery of proteins and peptides
|
BRPI0912384A2
(pt)
*
|
2008-05-07 |
2015-10-13 |
Merrion Res Iii Ltd |
composição, e, método para preparar uma composição
|
US20100004196A1
(en)
*
|
2008-06-17 |
2010-01-07 |
Hopitaux Universitaires De Geneve |
Heparan sulfate proteoglycan composition and use thereof
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
AU2010217213B2
(en)
*
|
2009-02-24 |
2013-05-23 |
Healor Ltd. |
Visfatin therapeutic agents for the treatment of acne and other conditions
|
US20100215743A1
(en)
*
|
2009-02-25 |
2010-08-26 |
Leonard Thomas W |
Composition and drug delivery of bisphosphonates
|
ES2600929T3
(es)
*
|
2009-09-10 |
2017-02-13 |
Merial, Inc. |
Nuevas formulaciones de vacuna que comprenden adyuvantes que contienen saponina
|
SG181487A1
(en)
*
|
2009-12-10 |
2012-07-30 |
Merck Patent Gmbh |
Pharmaceutical composition comprising oligopeptides, preferably cilengitide
|
EP2536421A4
(de)
|
2010-01-11 |
2013-10-09 |
Healor Ltd |
Verfahren zur behandlung von schuppenflechte
|
MX2012007806A
(es)
|
2010-01-12 |
2012-08-01 |
Novo Nordisk As |
Composiciones farmaceuticas para administracion oral de peptidos de insulina.
|
US20110182985A1
(en)
*
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
WO2011120033A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor xa inhibitors for oral administration
|
FR2964332A1
(fr)
*
|
2010-09-06 |
2012-03-09 |
Capsum |
Nanodispersions inverses stables
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9168309B2
(en)
|
2010-12-01 |
2015-10-27 |
Omnis Biotechnology Inc. |
Thixotropic compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
KR20140026354A
(ko)
|
2011-01-07 |
2014-03-05 |
메리온 리서치 Ⅲ 리미티드 |
경구 투여용 철의 제약 조성물
|
GB201107630D0
(en)
*
|
2011-05-06 |
2011-06-22 |
Proxima Concepts Ltd |
Microemulsions
|
KR102276161B1
(ko)
|
2011-10-25 |
2021-07-14 |
프로테나 바이오사이언시즈 리미티드 |
항체 제형 및 방법
|
EP3129002A4
(de)
*
|
2014-04-09 |
2017-11-08 |
Nanoceutica Laboratories Pvt. Ltd |
Zusammensetzung und verfahren zur herstellung einer nanoformulierung aus wasserunlöslichen bioaktiven stoffen in wässriger base
|
EP2946788A1
(de)
|
2014-05-23 |
2015-11-25 |
Immundiagnostik AG |
Verfahren und Zusammensetzung zur Behandlung von Herzversagen mit erhaltener Austreibungsfraktion
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
WO2016120378A1
(en)
|
2015-01-29 |
2016-08-04 |
Novo Nordisk A/S |
Tablets comprising glp-1 agonist and enteric coating
|
US9872832B2
(en)
*
|
2015-10-23 |
2018-01-23 |
LG Bionano, LLC |
Nanoemulsions having reversible continuous and dispersed phases
|
US20180077951A1
(en)
*
|
2016-09-16 |
2018-03-22 |
Kemin Industries, Inc. |
Animal feed supplement
|
CA3078723A1
(en)
|
2016-11-28 |
2018-05-31 |
Nachiappan Chidambaram |
Oral testosterone undecanoate therapy
|
KR101786914B1
(ko)
*
|
2017-01-31 |
2017-11-15 |
주식회사 삼양사 |
피부 리프팅 또는 탄력 개선을 위한 점착성 탄력 밴드
|
CN112915916B
(zh)
*
|
2021-01-29 |
2022-05-24 |
江南大学 |
一种pH刺激响应型胆汁盐Pickering复合乳化剂
|